Exquando uses cookies on this website to provide you with the best possible browsing experience. If you would like more information on the use of cookies, you can consult our Cookies policy. By continuing to browse or use our site without having accepted or refused cookies, only cookies essential for browsing our website are used. You can also choose to accept all cookies or customize their use. You can change your preferences at any time via the icon cookie
Accept
Configuration
Decline
cookie
Configurez les cookies / Cookies configuration / Cookies configuratie

(FR) Les cookies fonctionnels sont essentiels pour le fonctionnement du site internet et ne peuvent être désactivés. Pour améliorer votre expérience, d'autres cookies sont utilisés. Vous pouvez choisir de les désactiver. Ils restent modifiables à tout moment via cette fenêtre.

(EN) Functional cookies are essential for the operation of the website and cannot be deactivated. To improve your experience, other cookies are used. You can choose to turn them off. They can be modified at any time via this window.

(NL) Functionele cookies zijn essentieel voor de werking van de website en kunnen niet worden gedeactiveerd. Om uw ervaring te verbeteren, worden andere cookies gebruikt. U kunt ervoor kiezen om ze uit te schakelen. Ze kunnen op elk moment worden gewijzigd via dit venster.

Cookies fonctionnels / Functional cookies / Functionele cookies
Cookies d'analyse et de marketing / Analysis and marketing cookies / Analyse- en marketingcookies
En savoir plus sur la politique d'usage des cookies / Learn more about the use of cookies policy / Meer informatie over het gebruik van het cookiebeleid
Sauvegarder / Save / Sparen

News & Opinions

Should information be governed?

With a growing number of information to manage, we need to question ourself on the usefulness of an information governance.

Governance - How do we do together?

Governance is on every lips, but what does that word mean?

Exquando enters in a three-year collaboration agreement with GSK Biologicals for its document control services

GSK Biologicals recently announced its decision to entrust Exquando with a three-year collaboration.

Governance & Leadership

Often, we hear that we lacks of a true leader to solve problems that companies are facing. A super hero that we describe in this article.

Exquando selected as Preferred Supplier by a leading pharmaceutical company

Exquando selected as Preferred Supplier for profiles in document management by a leading pharmaceutical company.

Philippe Braibant appointed Independent Director of Exquando

At the Extraordinary General Meeting held this January 30, 2015, Philippe Braibant was appointed Independent Director of Exquando.